AuntMinnie
OCTOBER 17, 2024
The delayed restart of a nuclear research reactor in the Netherlands is expected to cause supply shortages of the imaging agent technetium-99 m (Tc-99m) into November, according to reports. “We anticipate that shortages of Mo-99 [Molybdenum-99] to Tc-99m generator manufacturers will begin later this week and increase next week,” said industry association Nuclear Medicine Europe (NMEU), in an October 14 letter to stakeholders.
Radiology Business
OCTOBER 17, 2024
East River Medical Imaging PC experienced the data breach sometime between August and September 2023, with over 533,000 individuals potentially impacted.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ScienceDaily
OCTOBER 17, 2024
Researchers developed an approach to treating prostate cancer, successfully eliminating cancerous cells in 73% of patients in the study.
Radiology Business
OCTOBER 17, 2024
"Application of these technologies represents potential areas to combat burnout," researchers wrote recently in the Journal of the American College of Radiology.
Advertisement
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Health Imaging
OCTOBER 17, 2024
The impending shortage pertains to molybdenum-99, or Mo-99. A structural issue has occurred with a pipe within the high-flux reactor in Petten, Netherlands, which will require an immediate repair.
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
ScienceDaily
OCTOBER 17, 2024
Researchers have analyzed down to the smallest detail the unusual arsenal of weapons that a predatory marine bacterium has at its disposal. Perhaps one day these weapons could also be put to use in medicine.
Health Imaging
OCTOBER 17, 2024
By reducing report variability, the software could help decrease unnecessary biopsies in patients with questionable lesions.
AuntMinnie
OCTOBER 17, 2024
More social support and living with a spouse or partner are tied to more breast cancer screening, according to research published October 17 by the American Cancer Society (ACS). A team led by Jordan Baeker Bispo, PhD, from the ACS found that overall, screening participation was supported by higher perceived social support among all cancer screening types included in the survey study, with the association being strongest for breast cancer screening.
Diagnostic Imaging
OCTOBER 17, 2024
Examining six comparative studies within a new meta-analysis, researchers found that FAPI PET/CT offered 11 percent higher pooled sensitivity and 28 percent higher pooled specificity than FDG PET/CT for diagnosing lymph node metastases in patients with lung cancer.
Advertisement
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
UCSF Biomedical Imaging
OCTOBER 17, 2024
This Medical Ultrasound Awareness Month, we proudly recognize the extraordinary skill and expertise of our sonographers.
Diagnostic Imaging
OCTOBER 17, 2024
When employing a PI-RADS > 4 cutoff, researchers found that the mdprostate software provided an 85.5 percent sensitivity rate for diagnosing clinically significant prostate cancer on mpMRI.
AuntMinnie
OCTOBER 17, 2024
The Institute for AI Governance in Healthcare (IAIGH) has released for public comment a document it calls Healthcare AI Governance Standard (HAIGS). According to the IAIGH , the HAIGS prioritizes patient safety, data security, equity, transparency, trust, and regulatory compliance. It also provides a framework for regulating AI in healthcare that is designed to be "scalable and adaptable, allowing organizations of all sizes and resource levels to implement it effectively.
Diagnostic Imaging
OCTOBER 17, 2024
Artificial intelligence has been transforming modern radiology in diagnostic accuracy, efficiency, and patient outcomes. What do the leading AI innovations offer in advancing imaging in practices?
Advertisement
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
UCSF Biomedical Imaging
OCTOBER 17, 2024
Jerome Taylor is the new evening CT Supervisor at the UCSF Medical Center.
Open Medscience
OCTOBER 17, 2024
The structure of the atom, with its electrons, protons, and neutrons, determines the fundamental properties of matter. The post Structure of the Atom: From Ancient Theories to Quantum Discoveries appeared first on Open MedScience.
UCSF Biomedical Imaging
OCTOBER 17, 2024
UCSF Health technologists host AHRA Leadership Meeting at Mission Bay.
JVIR
OCTOBER 17, 2024
The question of whether revascularization by open surgical means or endovascular techniques is preferable has led to various debates in the past, and recently, the BEST-CLI trial (1) has reignited the turf battle in the chronic limb-threatening ischemia (CLTI) field. As with all randomized controlled trials, the outcomes may not be translatable to the real-world population, given the typically highly restrictive inclusion criteria.
Advertisement
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
JVIR
OCTOBER 17, 2024
Percutaneous cryoablation (PCA) is recognized as a standard therapeutic option for patients with renal cell carcinoma (RCC) who are either unable or unwilling to undergo extirpative surgery; however, it is less effective for larger tumors, with local recurrence rates reported in ∼3%––39% of patients with T1b tumors (4.1–7 cm) (1,2). Transarterial embolization (TAE) of RCC prior to PCA has been described as a mechanism to help destroy the tumor and reduce bleeding adverse events (3–5).
MedImaging MRI
OCTOBER 17, 2024
A proposed multiscale transformer-based model for end-to-end segmentation of focal cortical dysplasia lesions from multi-channel MR images improves the feature.
JVIR
OCTOBER 17, 2024
To determine how low inorganic phosphate stress (LIPS) induced by sevelamer transartieral embolization (S-TAE) affects immune regulation and angiogenesis in hepatocellular carcinoma (HCC).
Advertisement
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
JVIR
OCTOBER 17, 2024
To investigate the outcomes of first-line image-guided microwave ablation (MWA) plus tyrosine kinase inhibitors (TKIs) in untreated epidermal growth factor receptor (EGFR)-mutant advanced lung adenocarcinoma (LUAD), and to compare with TKIs alone.
JVIR
OCTOBER 17, 2024
The aim of study is to investigate the efficacy of thoracic endovascular aortic repair for infectious aortic diseases.
JVIR
OCTOBER 17, 2024
To identify predictors of clinical success in invasive treatment for femoropopliteal disease aiding clinical decision-making.
JVIR
OCTOBER 17, 2024
The guideline regarding the maximum tolerated lung dose for Yttrium-90 (Y90) radioembolization is an expert opinion (level 5 evidence) based on a case series of 5 patients and recommends keeping the absorbed radiation dose to the lungs below 30 Gy per treatment and 50 Gy in a lifetime to prevent radiation pneumonitis (RP). The current understanding of the risks of RP is minimal despite its debilitating nature and high mortality rate.
Advertisement
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Expert insights. Personalized for you.
128 
Let's personalize your content